Preclinical pharmacokinetic, toxicological and biomarker evaluation of SR16157, a novel dual-acting steroid sulfatase inhibitor and selective estrogen receptor modulator.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1341, doi. 10.1007/s00280-010-1430-x
- By:
- Publication type:
- Article